Effect of Docosahexaenoic Acid on the Inflammatory Response and Clinical Outcomes From Surgical Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

September 30, 2012

Conditions
Severe SepsisOrgan Dysfunction Syndrome
Interventions
DIETARY_SUPPLEMENT

Docosahexaenoic acid

DHA have oil form. Each neonate is receiving 75 mg/kg/day of DHA in 188 uL/kg/day in two doses per day, since two days before surgery and over six days following cardiovascular surgery

DIETARY_SUPPLEMENT

Placebo

Placebo have oil form. Each neonate is receiving 188uL/kg/day of sunflower oil as placebo in two doses per day, since two days before surgery and over six days following cardiovascular surgery

Trial Locations (1)

06720

Unit of Research in Nutrition, Pediatric Hospital, Instituto Mexicano del Seguro Social, Mexico City

All Listed Sponsors
lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT01049529 - Effect of Docosahexaenoic Acid on the Inflammatory Response and Clinical Outcomes From Surgical Patients | Biotech Hunter | Biotech Hunter